We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-1.08%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$6.52B
AUM Growth
+$390M
Cap. Flow
+$499M
Cap. Flow %
7.66%
Top 10 Hldgs %
93.82%
Holding
176
New
34
Increased
22
Reduced
73
Closed
33

Top Buys

Rank Stock Value
1
SBIL
Simplify Government Money Market ETF
SBIL
+$239M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$130M
3
TUA icon
Simplify Short Term Treasury Futures Strategy ETF
TUA
+$120M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$56.1M
5
BUCK icon
Simplify Stable Income ETF
BUCK
+$40.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$28.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.5M
3
APLS
Apellis Pharmaceuticals
APLS
+$13.5M
4
AMGN icon
Amgen
AMGN
+$13M
5
LLY icon
Eli Lilly
LLY
+$11.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.07%
2 Healthcare 3.66%
3 Energy 0.49%
4 Industrials 0.27%
5 Technology 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
51
Abeona Therapeutics
ABEO
$343M
$2.28M 0.03%
507,988
+7,646
+2% +$38.2K
CLDX icon
52
Celldex Therapeutics
CLDX
$3.12B
$2.19M 0.03%
68,994
-16,006
-19% -$436K
MFA
53
MFA Financial
MFA
$905M
$2M 0.03%
209,000
+6,500
+3% +$64.1K
GH icon
54
Guardant Health
GH
$21.7B
$1.92M 0.03%
20,821
-8,760
-30% -$880K
MIST icon
55
Milestone Pharmaceuticals
MIST
$149M
$1.79M 0.03%
1,506,405
– –
OCS icon
56
Oculis Holding
OCS
$676M
$1.77M 0.03%
66,667
-32,098
-32% -$850K
WMT icon
57
Walmart Inc
WMT
$850B
$1.77M 0.03%
14,217
-1,277
-8% -$157K
INSM icon
58
Insmed
INSM
$27.6B
$1.76M 0.03%
10,783
-26,107
-71% -$4.01M
PLTR icon
59
Palantir
PLTR
$419B
$1.71M 0.03%
11,704
+1,963
+20% +$300K
ABT icon
60
Abbott
ABT
$187B
$1.59M 0.02%
15,506
-5,824
-27% -$658K
CSCO icon
61
Cisco
CSCO
$431B
$1.54M 0.02%
19,859
-501
-2% -$39.2K
LONA
62
LeonaBio Inc
LONA
$71.2M
$1.53M 0.02%
149,279
– –
CORT icon
63
Corcept Therapeutics
CORT
$12.1B
$1.52M 0.02%
+37,763
New +$1.41M
KYTX icon
64
Kyverna Therapeutics
KYTX
$510M
$1.49M 0.02%
173,106
-19,233
-10% -$160K
PCRX icon
65
Pacira BioSciences
PCRX
$1.05B
$1.42M 0.02%
62,653
-23,608
-27% -$525K
IVA
66
Inventiva
IVA
$1.13B
$1.26M 0.02%
227,923
-109,739
-32% -$669K
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.26M 0.02%
+2,622
New +$1.29M
IBM icon
68
IBM
IBM
$221B
$1.16M 0.02%
4,790
-62
-1% -$16.8K
EW icon
69
Edwards Lifesciences
EW
$51.8B
$1.13M 0.02%
14,078
-5,260
-27% -$434K
VRDN icon
70
Viridian Therapeutics
VRDN
$2.6B
$1.1M 0.02%
56,231
-47,300
-46% -$1.4M
NLY icon
71
Annaly Capital Management
NLY
$17.2B
$1.04M 0.02%
49,403
-30,252
-38% -$689K
DX
72
Dynex Capital
DX
$3.2B
$1.04M 0.02%
81,579
-25,421
-24% -$350K
AGNC icon
73
AGNC Investment
AGNC
$12.6B
$1.04M 0.02%
103,485
-23,552
-19% -$260K
OXLC
74
Oxford Lane Capital
OXLC
$947M
$978K 0.02%
+100,000
New +$1.1M
AQST icon
75
Aquestive Therapeutics
AQST
$670M
$972K 0.01%
+234,279
New +$951K
1 2
3
4 5

Similar funds

CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $7.18B AUM 18.15% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Simplify Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Simplify Asset Management held 176 positions worth $6.52B, up 6.4% from $6.13B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Simplify Asset Management deployed $499M of net new capital in Q1 2026, opening 34 new positions and adding to 22 existing holdings. Its largest new stake was Simplify Short Term Treasury Futures Strategy ETF: 5,528,700 shares worth $117M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 93% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was UnitedHealth, an estimated $28.9M trimmed.

  • Simplify Asset Management's largest Q1 2026 buy was Simplify Short Term Treasury Futures Strategy ETF: 5,528,700 shares worth $117M.
  • Simplify Asset Management added most to Simplify Government Money Market ETF in Q1 2026, an estimated $239M increase.
  • Simplify Asset Management's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $28.9M.
  • Simplify Asset Management fully exited Apellis Pharmaceuticals in Q1 2026, selling an estimated $13.5M.
  • Simplify Asset Management's ten largest holdings make up 94% of its $6.52B portfolio in Q1 2026.
  • Simplify Asset Management opened 34 new positions and closed 33 in Q1 2026.
  • Simplify Asset Management's portfolio value rose 6.4% quarter-over-quarter to $6.52B.

Based on Simplify Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.